1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	35_QUEST_clinical_caseMIR	SENT1	-	-
2	con	con	SPS00	C0332287	atributo	6-9	35_QUEST_clinical_caseMIR	SENT1	-	-
3	historia	historia	NCFS000	-	-	10-18	35_QUEST_clinical_caseMIR	SENT1	-	-
4	personal	personal	AQ0CS0	-	-	19-27	35_QUEST_clinical_caseMIR	SENT1	-	-
5	y	y	CC	C1706368	calificador	28-29	35_QUEST_clinical_caseMIR	SENT1	-	-
6	familiar	familiar	AQ0CS0	C0080103#C0241888	persona#calificador	30-38	35_QUEST_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332285	atributo	39-41	35_QUEST_clinical_caseMIR	SENT1	-	-
8	sangrado	sangrado	NCMS000	C0019080	hallazgo#anomalía_morfológica	42-50	35_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	por	por	SPS00	C0678226	atributo	51-54	35_QUEST_clinical_caseMIR	SENT1	-	-
10	mucosas	mucosa	NCFP000	C0026724	estructura_corporal	55-62	35_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
11	.	.	Fp	-	-	62-63	35_QUEST_clinical_caseMIR	SENT1	-	-

1	El	el	DA0MS0	-	-	64-66	35_QUEST_clinical_caseMIR	SENT2	-	-
2	estudio	estudio	NCMS000	C0557651	medio_ambiente	67-74	35_QUEST_clinical_caseMIR	SENT2	-	-
3	de	de	SPS00	C0332285	atributo	75-77	35_QUEST_clinical_caseMIR	SENT2	-	-
4	coagulación	coagulación	NCFS000	C0441509	procedimiento	78-89	35_QUEST_clinical_caseMIR	SENT2	-	-
5	presenta	presentar	VMIP3S0	-	-	90-98	35_QUEST_clinical_caseMIR	SENT2	-	-
6	un	un		C0205447_1	calificador_1	99-101	35_QUEST_clinical_caseMIR	SENT2	-	-
7	tiempo	tiempo	NCMS000	C0040223#C3541383	calificador#atributo#metadato_fundacional	102-108	35_QUEST_clinical_caseMIR	SENT2	-	-
8	de	de	SPS00	C0332285	atributo	109-111	35_QUEST_clinical_caseMIR	SENT2	-	-
9	hemorragia	hemorragia	NCFS000	C0019080	hallazgo#anomalía_morfológica	112-122	35_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
10	y	y	CC	C1706368	calificador	123-124	35_QUEST_clinical_caseMIR	SENT2	-	-
11	tiempo	tiempo	NCMS000	C0040223#C3541383	calificador#atributo#metadato_fundacional	125-131	35_QUEST_clinical_caseMIR	SENT2	-	-
12	de	de	SPS00	C0332285	atributo	132-134	35_QUEST_clinical_caseMIR	SENT2	-	-
13	tromboplastina	tromboplastina	NCFS000	C0040048	producto#sustancia	135-149	35_QUEST_clinical_caseMIR	SENT2	-	-
14	parcial	parcial	AQ0CS0	C0728938#C0205257#C0728939	calificador	150-157	35_QUEST_clinical_caseMIR	SENT2	-	-
15	activado	activar	VMP00SM	-	-	158-166	35_QUEST_clinical_caseMIR	SENT2	-	-
16	alargados	alargar	VMP00PM	-	-	167-176	35_QUEST_clinical_caseMIR	SENT2	-	-
17	.	.	Fp	-	-	176-177	35_QUEST_clinical_caseMIR	SENT2	-	-

1	Actividad	actividad	NCFS000	C0441655	entidad_observable	178-187	35_QUEST_clinical_caseMIR	SENT3	-	-
2	de	de	SPS00	C0332285	atributo	188-190	35_QUEST_clinical_caseMIR	SENT3	-	-
3	protrombina	protrombina	NCFS000	C0033706	sustancia	191-202	35_QUEST_clinical_caseMIR	SENT3	-	-
4	del	del	SP+DA	-	-	203-206	35_QUEST_clinical_caseMIR	SENT3	-	-
5	100	100	Z	-	-	207-210	35_QUEST_clinical_caseMIR	SENT3	-	-
6	%	%	Ft	-	-	210-211	35_QUEST_clinical_caseMIR	SENT3	-	-
7	.	.	Fp	-	-	211-212	35_QUEST_clinical_caseMIR	SENT3	-	-

